DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Topol EJ, Easton D, Harrington RA. Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators. et al
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
Circulation 2003; 108 (4) 399-406
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.